TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06163534: A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Sponsor: Tempus AI · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 500 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$3,973,200

Rescue Site Savings

+$2,633,400

Unlock Full NCT06163534 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06163534 Rescue Dossier →